References
- HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: European Centre for Disease Prevention and Control (ECDC); 2010. Available from: http://www.ecdc.europa.eu/en/publications/publications/101129_ter_hiv_testing_evidence.pdf
- Adler A, Mounier-Jack S, Coker RJ. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care 2009;21:284–93.
- Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med 2011;12:61–4.
- Lodi S, Phillips A, Touloumi G, Pantazis N, Bucher HC, Babiker A, et al. CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era. AIDS 2010;24:2697–704.
- Antiretroviral treatment of HIV infection 2013, updated recommendations. [Antiretroviral behandling av HIV-infektion 2013, uppdaterad rekommendation.] Swedish reference group for antiretroviral therapy (RAV); 2013. Available from: http://www.folkhalsomyndigheten.se/documents/projektwebbar/rav/rekommendationer/rav-behandling-antiviral-hivinfektion-2013-uppdaterad-version.pdf
- B rnighausen T, McWalter TA, Rosner Z, Newell ML, Welte A. HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology 2010;21:685–97.
- Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, Dobbs T, et al. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 2011;27:265–73.
- Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, et al. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010;24:2763–71.
- Guy R, Gold J, Calleja JM, Kim AA, Parekh B, Busch M, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis 2009;9:747–59.
- Methods for estimating HIV incidence. UNAIDS; 2010. Available from: http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/basedocument/2010/epi_alert_1stqtr2010_en.pdf
- Monitoring recently acquired HIV infections in the European context. Stockholm: European Centre for Disease Prevention and Control (ECDC); 2013. Available from: http://www.ecdc.europa.eu/en/publications/Publications/monitoring-recently-acquired-HIV-infections-european-context.pdf
- HIV in the United Kingdom: 2013 report. Health Protection Agency; 2013. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317140300680
- National Strategy to Combat HIV/AIDS and Certain Other Communicable Diseases. Government Bill 2005/06:60. [Nationell strategi mot hiv/aids och vissa andra smittsamma sjukdomar. Regeringens proposition 2005/06:60.] Available from: y
- Karlsson A, Björkman P, Bratt G, Ekvall H, Gisslén M, Sönnerborg A, et al. Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010. PloS One 2012;7:e33484.
- SPREADprogramme. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS 2008;22: 625–35.
- Skar H, Albert J, Leitner T. Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests. PloS One 2013;8:e60906.
- d’Arminio Monforte A, Cozzi-Lepri A, Girardi E, Castagna A, Mussini C, Di Giambenedetto S, et al. Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome. Antivir Ther 2011;16:1103–12.
- Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS 2006;20:2371–9.
- Chadborn TR, Baster K, Delpech VC, Sabin CA, Sinka K, Rice BD, et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002). AIDS 2005;19:513–20.
- Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta- analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446–53.
- Bontell I, Haggblom A, Bratt G, Albert J, Sonnerborg A. Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997–2011. PloS One 2013;8:e59337.
- Global AIDS Response Progress Report 2012, Sweden. Swedish Institute for Communicable Disease Control; 2012. Available from: http://www.folkhalsomyndigheten.se/pagefiles/12846/global-aids-response-progress-report.pdf
- Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505.
- Skar H, Axelsson M, Berggren I, Thalme A, Gyllensten K, Liitsola K, et al. Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland. J Virol 2011;85:510–18.
- Le Vu S, Le Strat Y, Barin F, Pillonel J, Cazein F, Bousquet V, et al. Population-based HIV-1 incidence in France, 2003-08: a modelling analysis. Lancet Infect Dis 2010;10:682–7.
- Bätzing-Feigenbaum J, Loschen S, Gohlke-Micknis S, Zimmermann R, Herrmann A, Kamga Wambo O, et al. Country-wide HIV incidence study complementing HIV surveillance in Germany. Euro Surveill 2008;13(36) pii:18971.
- Brännström J, Svedhem V, Yilmaz A, Blaxhult A, Wendahl S, Sönnerborg A. A high occurrence of late presenters and missed HIV diagnosis in clinical care in Sweden. Journal of the International AIDS Society 2010;13(Suppl 4):169.